AMA Honors Attorney with Lifetime Achievement Award

Translate to Spanish or other 102 languages!

Donald “Rocky” Wilcox Led TMA Legal Team for Decades. Courtesy Image
Donald “Rocky” Wilcox Led TMA Legal Team for Decades. Courtesy Image

Mega Doctor News

- Advertisement -

The American Medical Association (AMA) has honored Donald P. “Rocky” Wilcox, vice president and general counsel of the Texas Medical Association (TMA), with the Medical Executive Lifetime Achievement Award. The award honors a medical association executive who has contributed substantially to the goals and ideals of the medical profession.

Fort Worth allergist Susan R. Bailey, MD, AMA’s immediate past president and a former TMA president, honored Mr. Wilcox with the award this past weekend at TexMed, TMA’s annual meeting.

“Through many decades of service to our nation’s physicians, Rocky Wilcox has demonstrated his relentless dedication and passion for making a difference in medicine,” Dr. Bailey said. “His steadfast leadership and tireless efforts in the courts have helped protect and advance the practice of medicine for the better. It is an honor to recognize the unparalleled accomplishments of a fellow Texan who has championed many meaningful legal causes that affect physicians and patients across the nation.”

- Advertisement -

A U.S. Air Force veteran, Mr. Wilcox began his career in organized medicine at AMA’s Office of the General Counsel and Department of Health Law before taking on his current role at TMA, from which he will retire in June after 42 years.

Throughout his tenure at TMA, Mr. Wilcox has been instrumental in securing numerous legal victories for medicine, including a successful challenge to a Medicare $14 million recoupment, a favorable federal court ruling protecting patients and their physicians from insurer discrimination under the Americans with Disabilities Act, and settlements worth $1.5 billion in anti-racketeering class action lawsuits against a group of HMOs/insurers.

Beyond advocating for the physicians of Texas through the legal and legislative systems, Mr. Wilcox has continued to share his vast knowledge of health care law as the co-author of three books; contributing author for TMA’s Texas Medicine magazine and countless other health care publications; adjunct professor at The University of Texas School of Public Health Houston, San Antonio, and Austin campuses; and faculty member for the University of Houston MBA program for physicians.

Mr. Wilcox also helped organize and served on the board of directors for the Texas Alliance for Patient Access and chaired the American Society of Medical Association Counsel, among other appointments and memberships. He holds a legal counsel position at The Physicians Foundation and will continue to serve in that role in retirement. The State Bar of Texas Health Law Section, which he previously chaired, recognized Mr. Wilcox as its Distinguished Service Award recipient in 2016.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Study Projects Thousands of Missed Cancer Cases Under New Medicaid Rules

A research letter from experts at the University of Chicago Medicine, published in JAMA Oncology, warns that upcoming funding cuts and changes to federal Medicaid eligibility rules could lead to dramatic reductions in cancer screening for millions of Americans, ultimately worsening patient outcomes.

Pioneering New Frontiers in Myeloma Understanding and Care

esearch from Mayo Clinic is helping refine how multiple myeloma is diagnosed and treated, with findings that support more personalized therapies and identify promising immunotherapy strategies for aggressive forms of the disease.

Texas Surpasses $3 Billion in Opioid Settlements Following Newest Agreement

Attorney General Ken Paxton announced that a $7.4 billion settlement with Purdue Pharma, Inc. (“Purdue”) and its owners, the Sackler family, has become legally effective.

How a 5-Minute Skin Check Could Save Your Life

Today, May 4th marks Melanoma Monday, a day dedicated to raising awareness about the deadliest form of skin cancer. 
- Advertisement -